Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asoprisnil in Uterine Leiomyomata
NCT00160459Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- May 2000
- Primary completion
- Jul 2001
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of asoprisnil in uterine leiomyoma (4 arms), sponsored by Abbott Laboratories. Primary endpoints: Percent change from baseline in uterine volume and volume of the largest fibroid and Duration of amenorrhea. Started May 2000; status: completed.
02
Drugs
asoprisnil
03
Conditions
uterine leiomyoma
Beyond the preview
Go deeper on NCT00160459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160459.